Dr. Ramin Oskoui: COVID-19 pandemic treatment record

Dr. Ramin Oskoui's early 2020 evidence-based treatment protocol was shown to have excellent outcomes. Widespread use of Dr. Oskoui's protocol would have ended the pandemic much sooner. See all physicians.
c19early.org
COVID-19 TREATMENT RECORD — Dr. Oskoui vs. Dr. Fauci
RECOMMENDED
TREATMENTS
10 of 10
early recommendations
reduce risk
66 - 93% efficacy
$4.05 / treatment
PREDICTED
OUTCOME
2 months
343 deaths
$21 billion
RECOMMENDED
TREATMENTS
0 of 3
early recommendations
reduce risk
-26% efficacy
$4,060 / treatment
ACTUAL
OUTCOME
3 years
20 million deaths
$20 trillion
Dr. Ramin Oskoui
CENSORED
Dr. Anthony Fauci
10+ AWARDS
$0 $1,000 $2,000+ -25+% 0% 25% 50% Treatment cost (US$) Efficacy vs. cost: Dr. Oskoui's protocol vs. USA approved treatments +59 more high-profit drugs PPIs -46% BMS mAbs -36% Darunavir -34% Acetaminophen -28% Cenicriviroc -28% Cannabidiol Lufotrelvir Losartan Sargramostim Dexamethasone Lopinavir/ritonavir Ravulizumab Remdesivir Conv. Plasma Sarilumab Ibuprofen Masks Molnupiravir mutagenic/teratogenic Aspirin Tocilizumab Favipiravir Paxlovid Ratutrelvir Famotidine Vitamin C Sotrovimab Colchicine TMPRSS2 i.. NAC Amubarvimab/r.. Vilobelimab Azvudine Budesonide Probiotics HCQ Ensitrelvir Tixagevimab/c.. Zinc Antiandro.. Sleep Metformin Vitamin A Melatonin Bebtelovimab Nitric Oxide Quercetin H1RAs CPC Vitamin D H. Peroxide Exercise Fluvox. Sunlight Curcumin NaHCO₃ N. Sativa Casirivimab/i.. Bamlanivimab/e.. Ensovibep PVP-I pH+ Diet Regdanvimab Thermotherapy Ivermectin Dr. Oskoui US official Lowerrisk Higherrisk c19early.org August 2026 Dr. Oskoui's protocol combines low-cost evidence-basedtreatments with complementary and synergistic effects. Efficacyand cost are favorable compared with official treatments.c19early analyzes over 6,600 studies for 226 treatments.
$0 $1,000 $2,000+ -20+% 0% 25% 50% Treatment cost (US$) Efficacy vs. cost: Dr. Oskoui's protocol vs. USA approved +59 more high-profit drugs PPIs -46% BMS mAbs -36% Acetaminophen -28% Cenicriviroc -28% CBD -23% Lufotrelvir -22% Losartan Sargramostim Dexame.. Lopinav.. Vit. B9 Ravulizumab Remdesivir C. Plasma Sarilumab Ibuprofen Masks Molnupiravir mutagenic/teratogenic Aspirin Tocilizumab Favipir.. Paxlovid Ratutrelvir Famotidine Vitamin C Sotrovimab Colchicine TMPRSS2 i.. NAC Amubarvimab/r.. Vilobelimab Azvudine Budesonide Probiotics HCQ Tixagev.. Zinc Antiandro.. Sleep Metformin Vitamin A Melatonin Bebtelovimab Nitric Oxide Quercetin H1RAs CPC Vitamin D H. Peroxide Exercise Fluvox. Sunlight Curcumin NaHCO₃ N. Sativa Casirivim.. Bamlan.. Ensovibep PVP-I pH+ Diet Regdanvimab Thermotherapy Ivermectin Dr. Oskoui US official Lowerrisk Higherrisk c19early.org August 2026 Dr. Oskoui's protocol combineslow-cost evidence-basedtreatments. c19early analyzes over6,600 studies for 226 treatments.
c19early.org
Dr. Oskoui developed an evidence-based protocol for early COVID-19 treatment. Average treatment cost: $4.05. Predicted combined efficacy: 66%-93%.
CENSORED
Reference Studies Confirmed
beneficial
Outcomes Confidence
QuercetinQuercetin Early multidrug regimens..Early multid..1 9 January 20222 p = 0.0018
FamotidineFamotidine The Ingraham Angle - Osk..The Ingraham..3 29 October 20214 p = 0.00072
AzithromycinAzithromycin Early multidrug regimens..Early multid..1 30 Positive, small benefit5 p = 0.081
ZincZinc The Ingraham Angle - Osk..The Ingraham..3 41 July 20206 p = 0.00000012
Vitamin CVitamin C Early multidrug regimens..Early multid..1 72 September 20207 p < 0.0000001
FavipiravirFavipiravir Early multidrug regimens..Early multid..1 74 Positive, small benefit8 p = 0.0096
AspirinAspirin Early multidrug regimens..Early multid..1 79 Positive, small benefit9 p = 0.015
IvermectinIvermectin The Ingraham Angle - Osk..The Ingraham..10 106 August 202011 p < 0.0000001
Vitamin DVitamin D The Ingraham Angle - Osk..The Ingraham..12 138 October 202013 p < 0.0000001
HydroxychloroquineHCQ The Ingraham Angle - lat..The Ingraham..14 424 March 202015 p < 0.0000001
References